晕动病的预防用药评价_West China Medical Journal

Authors：

程凯 , 徐珽 , 胡海波 , 唐尧

Corresponding author：

Keywords：

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 程凯,徐珽,胡海波,唐尧. 晕动病的预防用药评价. West China Medical Journal, 2009, 24(4): 1063-1064. doi: Copy

1.	MURRAY J B. Psychophysiological aspects of motion sickness[J]. Percept Mot Skills,1997,85(3 pt 2):1163-1167..
2.	王尔贵,薜龙增,张炳新,等.晕动病的病因及防治[J].听力学及言语疾病杂志,2002,10(4):276-279..
3.	孙兴和.晕动病[J].辽宁医学杂志,1992,6(2):63-65..
4.	KODA-KIMBLE M A, YOUNG L Y, KRADJAN W A, et.al. Appliced Therapeutics:the clinical use of drugs 8e[M]. LIPPINCOTT WILLIAMS & WOLKINS,2005:8-5..
5.	李端.药理学第5版[M].人民卫生出版社,2003:275..
6.	BELLORINI J, CHAMBERLAIN J, BURTON M J. Antihistamines for motion sickness (Protocol)[J]. Cochrane Database Syst Rev,2008,23(2):CD007164..
7.	谭云龙,湛福中.晕动病的诊断治疗和预防[J].厂矿医药卫生,1997,13(1):43-44..
8.	熊正荣,蒲勇,杨清聪,等.茶苯海明加东莨菪碱预防晕车反应疗效观察[J].临床军医杂志,2006,34(3):386-387..
9.	WOOD C D. Antimotion sickness and antiemetic drugs[J]. Drugs,1979,17(6):471-479.
10.	BUCKEY J C, ALVARENGA D, COLE B, et al. Chlorpheniramine for motion sickness[J]. J Vestib Res,2004,14(1):53-61..
11.	BUCKEY J C, ALVARENGA D L, MACKENZIE T A. Chlorpheniramine and ephedrine in combination for motion sickness[J].J Vestib Res,2007,17(5-6):301-11..
12.	WEINSTEIN S E, STERN R M. Comparison of marezine and dramamine in preventing symptoms of motion sickness[J]. Aviat Space Environ Med,1997,68(10):890-894..
13.	SPINKS A, WASIAK J, VILLANUEVA E, et al. Scopolamine (hyoscine) for preventing and treating motion sickness[J]. Cochrane Database Syst Rev,2007,18(3):CD002851..
14.	王恩彤,何凌汉.晕动病的药物防治[J].空军总医院学报,1989,5(3):166,170..
15.	翟瑞灵,李冬梅,丁学开.多潘立酮治疗晕动病[J].中国新药与临床杂志,1998,17(6):376..
16.	于桂荣,包卫芹.吗丁琳治疗晕动病35例报告[J].山东医药,2002,42(34):2..
17.	叶国富.吗丁啉治疗晕动病50例疗效观察[J].青海医药杂志,1999,29(9):50..
18.	PINGREE B J. INM investigations into drugs for seasickness prophylaxis[J]. J R Nav Med Serv,1994,80(2):76-80..
19.	OOSTERVELD W J. The combined effect of cinnarizine and domperidone on vestibular susceptibility[J]. Aviat Space Environ Med,1987,58(3):218-223..
20.	OTTO B, RIEPL R L, KLOSE J, et al. μ-Opiate receptor agonists - a new pharmacological approach to prevent motion sickness?[J]Br J Clin Pharmacol,2005,61(1):27-30..

1. MURRAY J B. Psychophysiological aspects of motion sickness[J]. Percept Mot Skills,1997,85(3 pt 2):1163-1167..
2. 王尔贵,薜龙增,张炳新,等.晕动病的病因及防治[J].听力学及言语疾病杂志,2002,10(4):276-279..
3. 孙兴和.晕动病[J].辽宁医学杂志,1992,6(2):63-65..
4. KODA-KIMBLE M A, YOUNG L Y, KRADJAN W A, et.al. Appliced Therapeutics:the clinical use of drugs 8e[M]. LIPPINCOTT WILLIAMS & WOLKINS,2005:8-5..
5. 李端.药理学第5版[M].人民卫生出版社,2003:275..
6. BELLORINI J, CHAMBERLAIN J, BURTON M J. Antihistamines for motion sickness (Protocol)[J]. Cochrane Database Syst Rev,2008,23(2):CD007164..
7. 谭云龙,湛福中.晕动病的诊断治疗和预防[J].厂矿医药卫生,1997,13(1):43-44..
8. 熊正荣,蒲勇,杨清聪,等.茶苯海明加东莨菪碱预防晕车反应疗效观察[J].临床军医杂志,2006,34(3):386-387..
9. WOOD C D. Antimotion sickness and antiemetic drugs[J]. Drugs,1979,17(6):471-479.
10. BUCKEY J C, ALVARENGA D, COLE B, et al. Chlorpheniramine for motion sickness[J]. J Vestib Res,2004,14(1):53-61..
11. BUCKEY J C, ALVARENGA D L, MACKENZIE T A. Chlorpheniramine and ephedrine in combination for motion sickness[J].J Vestib Res,2007,17(5-6):301-11..
12. WEINSTEIN S E, STERN R M. Comparison of marezine and dramamine in preventing symptoms of motion sickness[J]. Aviat Space Environ Med,1997,68(10):890-894..
13. SPINKS A, WASIAK J, VILLANUEVA E, et al. Scopolamine (hyoscine) for preventing and treating motion sickness[J]. Cochrane Database Syst Rev,2007,18(3):CD002851..
14. 王恩彤,何凌汉.晕动病的药物防治[J].空军总医院学报,1989,5(3):166,170..
15. 翟瑞灵,李冬梅,丁学开.多潘立酮治疗晕动病[J].中国新药与临床杂志,1998,17(6):376..
16. 于桂荣,包卫芹.吗丁琳治疗晕动病35例报告[J].山东医药,2002,42(34):2..
17. 叶国富.吗丁啉治疗晕动病50例疗效观察[J].青海医药杂志,1999,29(9):50..
18. PINGREE B J. INM investigations into drugs for seasickness prophylaxis[J]. J R Nav Med Serv,1994,80(2):76-80..
19. OOSTERVELD W J. The combined effect of cinnarizine and domperidone on vestibular susceptibility[J]. Aviat Space Environ Med,1987,58(3):218-223..
20. OTTO B, RIEPL R L, KLOSE J, et al. μ-Opiate receptor agonists - a new pharmacological approach to prevent motion sickness?[J]Br J Clin Pharmacol,2005,61(1):27-30..

West China Medical Journal

晕动病的预防用药评价

Abstract Full text Figures/Tables Video References Cited by

Format

Content